OpenAI launches ChatGPT Health to connect user medical records, wellness apps

OpenAI launches ChatGPT Health to connect user medical records, wellness apps


OpenAI CEO Sam Altman attends an event to pitch AI for businesses in Tokyo, Feb. 3, 2025.

Kim Kyung-hoon | Reuters

OpenAI on Wednesday announced ChatGPT Health, which will allow users to securely connect their medical records and wellness apps to the artificial intelligence chatbot.

ChatGPT Health is not intended for diagnosis and treatment, and it’s not supposed to replace medical care, OpenAI said. Rather, the experience is supposed to help users navigate everyday questions, and it aims make ChatGPT’s responses more relevant by grounding them in a user’s own health information.

“ChatGPT Health is another step toward turning ChatGPT into a personal super-assistant that can support you with information and tools to achieve your goals across any part of your life,” Fidji Simo, CEO of applications at OpenAI, wrote in a post on Substack.

OpenAI said ChatGPT Health has its own dedicated space within the chatbot, so all of those files, conversations and connected apps are stored separately from other chats. Information and memories from ChatGPT Health will not flow outside of that space, and those conversations will not be used to train OpenAI’s foundation models, the company said.

The startup has partnered with b.well, which provides the health data connectivity infrastructure that will allow users to share their medical records with ChatGPT Health.

Users will also be able to connect to Apple Health, MyFitnessPal, Weight Watchers, the lab testing startup Function and other data. Services can be connected from tools or apps in settings.

ChatGPT Health was developed in “close collaboration” with physicians, OpenAI said.

OpenAI has deepened its push into health care in recent months.

After the company launched its GPT-5 model in August, OpenAI CEO Sam Altman told CNBC that health care was “maybe the area where there’s the strongest improvement of any category.”

In May, it released a benchmark called Health Bench that is designed to measure how well AI models perform in realistic health scenarios.

The startup said Wednesday that “hundreds of millions” of people ask health and wellness questions each week.

ChatGPT Health will initially be made available to a small group of early users that will offer feedback and refine the experience. OpenAI said it will expand access in the coming weeks.

WATCH: OpenAI seeks to hire new ‘head of preparedness’ to study risks

OpenAI seeks to hire new 'head of preparedness' to study risks



Source

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to  billion
Health

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion. OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from […]

Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More